Trial Profile
Safety Evaluation of the Maintenance treatment of Sorafenib in Hepatocellular carcinoma patients with Tumor thrombus after palliative surgery
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Jan 2019
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Carcinoma; Liver cancer
- Focus Adverse reactions
- 06 Jan 2019 Status changed from active, no longer recruiting to completed.
- 09 Dec 2016 Status changed from recruiting to active, no longer recruiting.
- 07 Jul 2011 New trial record